TG-2349, A POTENT PROTEASE INHIBITOR, PLUS PEGIFN/RBV PROVIDES EXCELLENT VIROLOGICAL RESPONSES FOR HARDER-TO-TREAT SUBPOPULATIONS OF HCV-1B NON-CIRRHOTIC PATIENTS

臺大醫院;臺大醫院雲林分院;臺大醫學院-臨床醫學研究所;Yu, M. -L.M. -L.YuHsu, S. -J.S. -J.HsuYeh, C. -T.C. -T.YehHung, C. -H.C. -H.HungChen, M. -Y.M. -Y.ChenChen, P. -J.P. -J.ChenHuang, Y. -H.Y. -H.HuangCheng, P. -N.P. -N.ChengChen, C. -M.C. -M.ChenChang, L. -W.L. -W.ChangLin, C. -C.C. -C.LinSheen, F.F.SheenKing, C. -H. R.C. -H. R.KingKuo, E.E.KuoHsu, M. -C.M. -C.Hsu陳培哲2017-06-222018-07-062017-06-222018-07-062016http://ntur.lib.ntu.edu.tw//handle/246246/279995TG-2349, A POTENT PROTEASE INHIBITOR, PLUS PEGIFN/RBV PROVIDES EXCELLENT VIROLOGICAL RESPONSES FOR HARDER-TO-TREAT SUBPOPULATIONS OF HCV-1B NON-CIRRHOTIC PATIENTS10.1016/S0168-8278(16)01559-2